• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴林的炎症性肠病:单中心经验

Inflammatory bowel disease in Bahrain: single-center experience.

作者信息

Abdulla Maheeba, Al Saeed Mahmood, Fardan Rawdha Hameed, Alalwan Hawra Faisal, Ali Almosawi Zahra S, Almahroos Amal Fuad, Al Qamish Jehad

机构信息

Department of Internal Medicine, Salmaniya Medical Complex, Manama, Bahrain.

Ibn Al Nafees Hospital, Manama, Bahrain.

出版信息

Clin Exp Gastroenterol. 2017 Jul 14;10:133-145. doi: 10.2147/CEG.S127909. eCollection 2017.

DOI:10.2147/CEG.S127909
PMID:28765713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5524702/
Abstract

PURPOSE

The number of newly diagnosed inflammatory bowel disease (IBD) cases such as ulcerative colitis (UC), Crohn's disease (CD), and indeterminate colitis (IC) is rapidly increasing in Gulf countries and Saudi Arabia. The aim of this study was to investigate the incidence and prevalence of IBD in patients who have attended the Salmaniya Medical Complex, Bahrain, between the years 1984 and 2014.

PATIENTS AND METHODS

All patients who had attended the Salmaniya Medical Complex, Bahrain, and had been diagnosed with UC, CD, or IC, between the years 1984 and 2014, were included in the analysis. Data collected were: patient demographics, symptoms, clinical signs, complications, surgical interventions, extent of disease, endoscopic findings, histopathology, and lab measurements.

RESULTS

A total of 187 cases were included; 61 had CD, 123 had UC, and a further 3 cases presented with IC. A clear increase in the incidence and prevalence of IBD can be seen in this cohort. The prevalence of IBD was calculated to be 26.25/10 cases. The average number of IBD cases increased from 3 cases (average for the years 1984-2001) to 12 cases (average for the years 2002-2014). A number of factors correlate positively or negatively with CD and UC. In the current study, a link between gastrointestinal complications in CD cases and the use of steroids as a treatment was noted (-value -0.02). Age also had a significant influence on the need for surgery in CD cases (-value -0.04), and a family history of UC was statistically linked to surgical intervention (-value -0.05).

CONCLUSIONS

IBD can no longer be considered a rare disease in Bahrain. The incidence of both UC and CD is steadily increasing. There is a need for increasing awareness of the Bahraini public to IBD in order for proper medical care to be given.

摘要

目的

在海湾国家和沙特阿拉伯,新诊断出的炎症性肠病(IBD)病例数量,如溃疡性结肠炎(UC)、克罗恩病(CD)和未定型结肠炎(IC)正在迅速增加。本研究的目的是调查1984年至2014年间在巴林萨尔曼尼亚医疗中心就诊的患者中IBD的发病率和患病率。

患者与方法

纳入分析的患者为1984年至2014年间在巴林萨尔曼尼亚医疗中心就诊且被诊断为UC、CD或IC的所有患者。收集的数据包括:患者人口统计学信息、症状、临床体征、并发症、手术干预、疾病范围、内镜检查结果、组织病理学以及实验室检测结果。

结果

共纳入187例病例;其中61例为CD,123例为UC,另有3例为IC。在这一队列中可明显看出IBD的发病率和患病率有所增加。IBD的患病率经计算为26.25/10万例。IBD病例的平均数量从3例(1984 - 2001年的平均值)增加到12例(2002 - 2014年的平均值)。一些因素与CD和UC呈正相关或负相关。在本研究中,注意到CD病例的胃肠道并发症与使用类固醇作为治疗之间存在关联(P值 - 0.02)。年龄对CD病例的手术需求也有显著影响(P值 - 0.04),UC家族史与手术干预在统计学上相关(P值 - 0.05)。

结论

在巴林,IBD不能再被视为罕见疾病。UC和CD的发病率都在稳步上升。需要提高巴林公众对IBD的认识,以便提供适当的医疗护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3912/5524702/a2e352e7c805/ceg-10-133Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3912/5524702/a2e352e7c805/ceg-10-133Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3912/5524702/a2e352e7c805/ceg-10-133Fig1.jpg

相似文献

1
Inflammatory bowel disease in Bahrain: single-center experience.巴林的炎症性肠病:单中心经验
Clin Exp Gastroenterol. 2017 Jul 14;10:133-145. doi: 10.2147/CEG.S127909. eCollection 2017.
2
A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.一项针对马来西亚吉隆坡单一三级医疗中心炎症性肠病患者发病率趋势、社会人口学和临床特征的四十年分析。
BMC Public Health. 2019 Jun 13;19(Suppl 4):550. doi: 10.1186/s12889-019-6858-2.
3
Clinical presentation of inflammatory bowel disease in Saudi children (Single centre experience).沙特儿童炎症性肠病的临床表现(单中心经验)
Int J Pediatr Adolesc Med. 2016 Dec;3(4):175-179. doi: 10.1016/j.ijpam.2016.08.004. Epub 2016 Sep 15.
4
A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia.沙特阿拉伯中北部地区炎症性肠病的流行病学、临床及表型特征研究
Diagnostics (Basel). 2023 Jun 21;13(13):2135. doi: 10.3390/diagnostics13132135.
5
Analysis and prediction of nutritional outcome of patients with pediatric inflammatory bowel disease from Bahrain.巴林小儿炎症性肠病患者营养结局的分析与预测
BMC Pediatr. 2024 Apr 24;24(1):265. doi: 10.1186/s12887-024-04720-3.
6
Natural history and outcome of inflammatory bowel diseases in children in Saudi Arabia: A single-center experience.沙特阿拉伯儿童炎症性肠病的自然病史及转归:单中心经验
Saudi J Gastroenterol. 2018 May-Jun;24(3):171-176. doi: 10.4103/sjg.SJG_490_17.
7
Nutritional status of children with inflammatory bowel disease in Saudi Arabia.沙特阿拉伯炎症性肠病患儿的营养状况。
World J Gastroenterol. 2016 Feb 7;22(5):1854-8. doi: 10.3748/wjg.v22.i5.1854.
8
[Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].1977年至2001年匈牙利西部维斯普雷姆县炎症性肠病的流行病学
Orv Hetil. 2003 Sep 14;144(37):1819-27.
9
Paediatric Inflammatory Bowel Disease: Clinical Presentation and Disease Location.小儿炎症性肠病:临床表现与疾病部位
Pak J Med Sci. 2017 Jul-Aug;33(4):793-797. doi: 10.12669/pjms.334.12926.
10
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.

引用本文的文献

1
The Role of the Gut Microbiome in Inflammatory Bowel Disease: The Middle East Perspective.肠道微生物群在炎症性肠病中的作用:中东视角
J Pers Med. 2024 Jun 18;14(6):652. doi: 10.3390/jpm14060652.
2
Awareness of inflammatory bowel disease among the general population of Al-Baha region, Saudi Arabia.沙特阿拉伯 Al-Baha 地区普通民众对炎症性肠病的认知。
J Med Life. 2024 Feb;17(2):164-170. doi: 10.25122/jml-2023-0463.
3
Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysis.中东地区(EMRO)国家炎症性肠病的流行病学特征:系统评价和荟萃分析。
BMC Public Health. 2024 May 24;24(1):1395. doi: 10.1186/s12889-024-18816-z.
4
Epidemiological research, burden, and clinical advances of inflammatory bowel disease in China.中国炎症性肠病的流行病学研究、疾病负担及临床进展
Chin Med J (Engl). 2024 May 5;137(9):1009-1011. doi: 10.1097/CM9.0000000000003064. Epub 2024 Mar 28.
5
A systematic review and meta-analysis of extra-intestinal manifestation of inflammatory bowel disease in the Eastern Mediterranean Region (EMRO) countries.东地中海区域(EMRO)国家炎症性肠病肠外表现的系统评价与荟萃分析。
Ann Med Surg (Lond). 2024 Apr 15;86(5):2892-2899. doi: 10.1097/MS9.0000000000001543. eCollection 2024 May.
6
Surgical outcomes and stoma-related complications in inflammatory bowel disease in Saudi Arabia: a retrospective study.沙特阿拉伯炎症性肠病的手术结果和造口相关并发症:一项回顾性研究。
Ann Saudi Med. 2023 Nov-Dec;43(6):386-393. doi: 10.5144/0256-4947.2023.386. Epub 2023 Dec 7.
7
Ethnic Issues and Disparities in Inflammatory Bowel Diseases: What Can We Learn from the Arab Population in Israel?炎症性肠病中的种族问题与差异:我们能从以色列的阿拉伯人群中学到什么?
J Pers Med. 2023 Jun 17;13(6):1008. doi: 10.3390/jpm13061008.
8
Clinical profile, course and outcomes of adults with inflammatory bowel disease over a decade: a single center experience.炎症性肠病成人患者十余年的临床特征、病程和转归:单中心经验。
Ann Saudi Med. 2022 Nov-Dec;42(6):397-407. doi: 10.5144/0256-4947.2022.397. Epub 2022 Dec 1.
9
Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience.巴林炎症性肠病患者生物治疗的早期停药:真实世界经验
Saudi J Gastroenterol. 2022 May-Jun;28(3):193-200. doi: 10.4103/sjg.sjg_336_21.
10
Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis.阿拉伯世界炎症性肠病的发病率、患病率及临床流行病学:一项系统评价与荟萃分析
Inflamm Intest Dis. 2021 Sep 7;6(3):123-131. doi: 10.1159/000518003. eCollection 2021 Sep.

本文引用的文献

1
Changing epidemiological trends of inflammatory bowel disease in Asia.亚洲炎症性肠病流行病学趋势的变化
Intest Res. 2016 Apr;14(2):111-9. doi: 10.5217/ir.2016.14.2.111. Epub 2016 Apr 27.
2
The Future of IBD Therapy: Where Are We and Where Should We Go Next?炎症性肠病治疗的未来:我们现状如何以及下一步该何去何从?
Dig Dis. 2016;34(1-2):175-9. doi: 10.1159/000443135. Epub 2016 Mar 16.
3
Influence of environmental factors in the development of inflammatory bowel diseases.环境因素对炎症性肠病发展的影响。
World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):112-25. doi: 10.4292/wjgpt.v7.i1.112.
4
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.英夫利昔单抗诱导治疗对肿瘤坏死因子拮抗剂治疗失败的克罗恩病患者的影响。
Gastroenterology. 2014 Sep;147(3):618-627.e3. doi: 10.1053/j.gastro.2014.05.008. Epub 2014 May 21.
5
Inflammatory bowel disease: an expanding global health problem.炎症性肠病:一个日益严重的全球健康问题。
Clin Med Insights Gastroenterol. 2013 Aug 14;6:33-47. doi: 10.4137/CGast.S12731. eCollection 2013.
6
Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases.沙特门诊新兴炎症性肠病:693 例报告。
Saudi J Gastroenterol. 2013 Jan-Feb;19(1):16-22. doi: 10.4103/1319-3767.105915.
7
Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients.沙特阿拉伯的炎症性肠病:一项基于医院的312例患者临床研究。
Ann Saudi Med. 2012 May-Jun;32(3):276-82. doi: 10.5144/0256-4947.2012.276.
8
Inflammatory bowel disease in Asia: a systematic review.亚洲的炎症性肠病:系统综述。
J Gastroenterol Hepatol. 2012 Aug;27(8):1266-80. doi: 10.1111/j.1440-1746.2012.07150.x.
9
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.基于系统评价,炎症性肠病的发病率和患病率随时间逐渐增加。
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001. Epub 2011 Oct 14.
10
Clinical epidemiology of Crohn's disease in Arabs based on the Montreal Classification.基于蒙特利尔分类的阿拉伯人克罗恩病的临床流行病学。
Inflamm Bowel Dis. 2012 Sep;18(9):1689-97. doi: 10.1002/ibd.21890. Epub 2011 Oct 10.